These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 28573622

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Ebola viral dynamics in nonhuman primates provides insights into virus immuno-pathogenesis and antiviral strategies.
    Madelain V, Baize S, Jacquot F, Reynard S, Fizet A, Barron S, Solas C, Lacarelle B, Carbonnelle C, Mentré F, Raoul H, de Lamballerie X, Guedj J.
    Nat Commun; 2018 Oct 01; 9(1):4013. PubMed ID: 30275474
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Development of Potential Small Molecule Therapeutics for Treatment of Ebola Virus Disease.
    Schafer A, Cheng H, Lee C, Du R, Han J, Perez J, Peet N, Manicassamy B, Rong L.
    Curr Med Chem; 2018 Oct 01; 25(38):5177-5190. PubMed ID: 29032747
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Antiviral Screening of Multiple Compounds against Ebola Virus.
    Dowall SD, Bewley K, Watson RJ, Vasan SS, Ghosh C, Konai MM, Gausdal G, Lorens JB, Long J, Barclay W, Garcia-Dorival I, Hiscox J, Bosworth A, Taylor I, Easterbrook L, Pitman J, Summers S, Chan-Pensley J, Funnell S, Vipond J, Charlton S, Haldar J, Hewson R, Carroll MW.
    Viruses; 2016 Oct 27; 8(11):. PubMed ID: 27801778
    [Abstract] [Full Text] [Related]

  • 35. Prophylactic Efficacy of Quercetin 3-β-O-d-Glucoside against Ebola Virus Infection.
    Qiu X, Kroeker A, He S, Kozak R, Audet J, Mbikay M, Chrétien M.
    Antimicrob Agents Chemother; 2016 Sep 27; 60(9):5182-8. PubMed ID: 27297486
    [Abstract] [Full Text] [Related]

  • 36. Progress towards the treatment of Ebola haemorrhagic fever.
    Ströher U, Feldmann H.
    Expert Opin Investig Drugs; 2006 Dec 27; 15(12):1523-35. PubMed ID: 17107278
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Targeting Ebola virus replication through pharmaceutical intervention.
    Hansen F, Feldmann H, Jarvis MA.
    Expert Opin Investig Drugs; 2021 Mar 27; 30(3):201-226. PubMed ID: 33593215
    [Abstract] [Full Text] [Related]

  • 39. Evaluation of the Activity of Lamivudine and Zidovudine against Ebola Virus.
    Cong Y, Dyall J, Hart BJ, DeWald LE, Johnson JC, Postnikova E, Zhou H, Gross R, Rojas O, Alexander I, Josleyn N, Zhang T, Michelotti J, Janosko K, Glass PJ, Flint M, McMullan LK, Spiropoulou CF, Mierzwa T, Guha R, Shinn P, Michael S, Klumpp-Thomas C, McKnight C, Thomas C, Eakin AE, O'Loughlin KG, Green CE, Catz P, Mirsalis JC, Honko AN, Olinger GG, Bennett RS, Holbrook MR, Hensley LE, Jahrling PB.
    PLoS One; 2016 Mar 27; 11(11):e0166318. PubMed ID: 27902714
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.